Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 198-207 , September 2007

Atomic force microscopy evaluation of the effects of a novel antimicrobial multimeric peptide on Pseudomonas aeruginosa

  • Greta Rossetto, MS

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Paolo Bergese, PhD

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Paolo Colombi, PhD

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • Corresponding Author InformationCorresponding author. INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Via Branze 38, 25123 Brescia, Italy.
    • ,
  • Laura E. Depero

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Andrea Giuliani, PhD

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy
    • ,
  • Silvia F. Nicoletto, MS

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy
    • ,
  • Giovanna Pirri, MD, MS

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy

Received 27 April 2007 ,Accepted 22 June 2007.

References 

  1. Hancock REW. Peptide antibiotics. Lancet. 1997;349:418–422
  2. Wu M, Maier E, Benz R, Hancock RE. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 1999;38:7235–7242
  3. Pereira HA. Novel therapies based on cationic antimicrobial peptides. CurrPharmacol Biotechnol. 2006;7:229–234
  4. Zhang L, Falla TJ. Antimicrobial peptides: therapeutic potential. Exp Opin Pharmacother. 2006;7:653–663
  5. Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol. 1995;13:61–92
  6. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–395
  7. Marcus JP, Green JL, Goulter KC, Manners JM. A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels. J Plant. 1999;19:699–710
  8. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491–511
  9. Wang Z, Wang G. APD: the antimicrobial peptide database. Nucleic Acids Res. 2004;32(Database issue):D590–D592
  10. Dijkshoorn L, Brouwer CPJM, Bogaards SJP, Nemec A, van den Broek PJ, Nibbering PH. The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumanni. Antimicrob Agents Chemother. 2004;48:4919–4921
  11. Mohammad FV, Noorwala M, Ahmad VU, Sener B. Bidesmosidic triterpenoidal saponins from the roots of Symphytum officinale. Planta Med. 1995;61:94
  12. Aley SB, Zimmerman M, Hetsko M, Selsted ME, Gillin FD. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun. 1994;62:5397–5403
  13. Hancock REW, Lehrer R. Cationic peptides: a new source of antibiotics. TibTech. 1998;16:82–87
  14. Bracci L, Falciani C, Lelli B, Lozzi L, Runci Y, Pini A, et al. Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem. 2003;278:46590–46595
  15. Pini A, Giuliani A, Falciani C, Runci Y, Ricci C, Lelli B, et al. Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother. 2005;49:2665–2672
  16. Tam PJ, Lu Y-A, Yang J-L. Antimicrobial dendrimeric peptides. Eur J Biochem. 2002;269:923–932
  17. Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J Antimicrob Chemother. 1999;44:641–645
  18. Hancock REW, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother. 1999;43:1317–1323
  19. Zhang L, Dhillon P, Yan H, Farmer S, Hancock REW. Interaction of bacterial cationic peptide with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3317–3321
  20. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanism of action. Biochim Biophys Acta. 1999;1462:11–28
  21. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defence? Magainins and tachyplesins as archetypes. Biochim Biophys Acta. 1999;1462:1–10
  22. Alessandrini A, Facci P. AFM: a versatile tool in biophysics. Meas Sci Technol. 2005;16:R65–R92
  23. Dufrêne YF, Müller DJ. Microbial surfaces investigated using atomic force microscopy. Methods Microb. 2005;34:163–197
  24. Santos NC, Castano MARB. An overview of the biophysical applications of atomic force microscopy. Biophys Chem. 2003;107:133–149
  25. Bolshakova AV, Kiselyova OI, Filonov AS, Frolova OY, Lyubchenko YL, Yaminsky IV. Comparative studies of bacteria with an atomic force microscopy operating in different modes. Ultramicroscopy. 2001;86:121–128
  26. Robichon D, Girard J-C, Cenatiempo Y, Cavellier J-F. Atomic force microscopy imaging of dried or living bacteria. Life Sci. 1999;322:687–693
  27. Doktycz MJ, Sullivan CJ, Hoyt PR, Pelletier DA, Wu S, Allison DP. AFM imaging of bacteria in liquid media immobilized on gelatin coated mica surfaces. Ultramicroscopy. 2003;97:209–216
  28. Nishino T, Ikemoto E, Kogure K. Application of atomic force microscopy to observation of marine bacteria. J Oceanography. 2004;60:219–225
  29. Umeda A, Saito M, Amako K. Surface characteristics of Gram-negative and Gram-positive bacteria in an atomic force microscope image. Microbiol Immunol. 1998;42:159–164
  30. Kasas S, Fellay B, Cargnello R. Observation of the action of penicillin on Bacillus subtilis using atomic force microscopy: technique for the preparation of bacteria. Surf Interface Anal. 1994;21:400–401
  31. da Silva A, Teschke O. Dynamics of the antimicrobial peptide PGLa action on Escherichia coli monitored by atomic force microscopy. World J Microbiol Biotechnol. 2005;21:1103–1110
  32. Braga PC, Ricci D. Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime. Antimicrob Agents Chemother. 1998;42:18–22
  33. Sharma S, Sen P, Mukhopadhyay SN, Guha SK. Microbicidal male contraceptive-risug induced morphostructural damage in E. coli. Colloids Surf B Biointerfaces. 2003;32:43–50
  34. Peng L, Yi L, Zhexue L, Juncheng Z, Jiaxin D, Daiwen P, et al. Study on biological effect of La3+ on Escherichia coli by atomic force microscopy. J Inorg Biochem. 2004;98:68–72
  35. Meincken M, Holroyd DL, Rautenbach M. Atomic force microscopy study of the effects of antimicrobial peptides on the cell envelope of Escherichia coli. Antimicrob Agents Chemother. 2005;49:4085–4092
  36. Li A, Lee PY, Ho B, Ding JL, Lim CT. Atomic force microscopy study of the antimicrobial action of Sushi peptides on Gram negative bacteria. Biochimica et Biophysica Acta. 2007;1768:411–418
  37. Hassan A-E, Heinz WF, Antonik MD, D'Costa NP, Nageswaran S, Schoenenberger C, et al. Relative microelastic mapping of living cells by atomic force microscopy. J. Biophys. 1998;74:1564–1578
  38. Bolshakova AV, Kiselyova OI, Yaminsky IV. Microbial surfaces investigated using atomic force microscopy. Biotechnol Prog. 2004;20:1615–1622
  39. Boulbitch A. Deformation of the envelope of a spherical Gram-negative bacterium during the atomic force microscopy measurements. J Electron Microsc. 2000;49:459–462
  40. Arnoldi M, Fritz M, Bäuerlein E, Radmacher M, Sackmann E, Boulbitch A. Bacterial turgor pressure can be measured by atomic force microscopy. Phys E Rev. 2000;62:1034–1044
  41. Yao X, Walter J, Burke S, Stewart S, Jericho M, Pink D, et al. Atomic force microscopy and theoretical consideration of surface properties and turgor pressure of bacteria. Colloids Surf B Biointerfaces. 2001;23:213–230
  42. Thwaites JJ, Surana UC. Mechanical properties of Bacillus subtilis cell walls: effects of removing residual culture medium. J Bacteriol. 1991;173:197–203
  43. Yao X, Jericho M, Pink D, Beveridge T. Thickness and elasticity of Gram-negative Murein sacculi measured by atomic force microscopy. J Bacteriol. 1999;181:6865–6875

 The authors declare competing financial interests. A. Giuliani is an executive board member and minor shareholder of SpiderBiotech which is developing antimicrobial peptides. G. Pirri is head of research and minor shareholder of SpiderBiotech.

PII: S1549-9634(07)00091-3

doi: 10.1016/j.nano.2007.06.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 198-207 , September 2007

Article Tools

* Image Usage & Resolution